Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases (Q44189751)

From Wikidata
Jump to navigation Jump to search
scientific article published on 5 September 2002
edit
Language Label Description Also known as
English
Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases
scientific article published on 5 September 2002

    Statements

    Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases (English)
    Markus Warmuth
    Nicola Simon
    Olga Mitina
    Ruth Mathes
    Doriano Fabbro
    Paul W Manley
    Elisabeth Buchdunger
    Karin Forster
    Ismail Moarefi
    5 September 2002
    664-672

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit